CD34 and acute lymphoblastic leukemia: Two other early studies suggested an association between CD34‐positive BCP‐ALL and a favorable outcome [49, 50] but were limited by reduced sensitivity due to few FCM‐acquired cells and/or hemodilution [49], as well as lack of cytogenetic analysis for rearrangements involving KMT2A [49, 50].